Evidence
Int J Neuropsychopharmacol. 2023 Jun 21:pyad032. doi: 10.1093/ijnp/pyad032. Online ahead of print.
ABSTRACT
BACKGROUND: Evidence has accumulated demonstrating the existence of opioid receptor heteromers and recent data suggest that targeting these heteromers could reduce opioid side effects while retaining therapeutic effects. Indeed, CYM51010 characterised as a MOR (mu opioid receptor)/DOR (delta opioid receptor) heteromers preferring agonist promoted antinociception comparable to morphine but with less tolerance. In the perspective of developing these new classes of pharmacological agents, data on their putative side effects are mandatory.
METHODS: Therefore, in this study, we investigated the effects of CYM51010 in different models related to drug addiction in mice including behavioural sensitization, conditioned place preference and withdrawal.
RESULTS: We found that, like morphine, CYM51010 promoted acute locomotor activity as well as psychomotor sensitization and rewarding effect. However, it induced less physical dependence than morphine. We also investigated the ability of CYM51010 to modulate some morphine-induced behaviour. Whereas CYM51010 was unable to block morphine-induced physical dependence, it blocked reinstatement of an extinguished morphine induced-conditioned place preference.
CONCLUSIONS: Altogether, our results reveal that targeting MOR-DOR heteromers could represent a promising strategy to block morphine reward.
PMID:37343217 | DOI:10.1093/ijnp/pyad032
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Peptide-derived ligands for the discovery of safer opioid analgesics
- Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype
- Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation
- The effect of morphine administration on GluN3B NMDA receptor subunit mRNA expression in rat brain
- Selective targeting of mu opioid receptors to primary cilia
- Selective targeting of mu opioid receptors to primary cilia
- Tiam1-mediated maladaptive plasticity underlying morphine tolerance and hyperalgesia
- Tiam1-mediated maladaptive plasticity underlying morphine tolerance and hyperalgesia
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice
- Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice
- Mimicking opioid analgesia in cortical pain circuits
- Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients
- Modulation of Nicotine-Associated Behaviour in Rats By μ-Opioid Signals from the Medial Prefrontal Cortex to the Nucleus Accumbens Shell
- Opioid consumption before discharge predicts outpatient opioid use in adolescents undergoing surgery
- Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review
- Establishing a research agenda for the study and assessment of opioid withdrawal
- Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pKa Fluorinated Fentanyl Analogs, FF3 and NFEPP
- The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
- Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures
- Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
- Ketamine For Acute Pain After Trauma (KAPT): A Pragmatic, Randomized Clinical Trial
- Opioid Overdose-Induced Diffusion Restriction in the Bilateral Basal Ganglia Revealed on Brain Imaging
- Impact of opioid maintenance therapy in the community on reincarceration in individuals with opioid use disorder-A linked cohort study
- Experiences and perspectives of adults on using opioids for pain management in the postoperative period: A scoping review
- Prescription Opioid Dose Change Prior to Fatal Opioid-Detected Overdose
- Bilateral ultrasound-guided maxillary and mandibular combined nerves block reduces morphine consumption after double-jaw orthognathic surgery: a randomized controlled trial
- Opioid use and risks in liver transplant candidates and recipients
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity
- The single-cell opioid responses in the context of HIV (SCORCH) consortium
- The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
- Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1
- Acute nicotine administration reduces the efficacy of punishment in curbing remifentanil consumption in a seeking-taking chain schedule of reinforcement
- Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
- Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study
- Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study
- Discriminative stimulus properties of Cannabis sativa terpenes in rats
- Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) study
- A master regulator of opioid reward in the ventral prefrontal cortex
- A master regulator of opioid reward in the ventral prefrontal cortex
- How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis
- How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis
- Time trends in opioid use for patients undergoing hip fracture surgery in 1997-2018: A Danish population-based cohort study
- Suprazygomatic Maxillary Nerve Blocks and Opioid Requirements in Pediatric Adenotonsillectomy: A Randomized Clinical Trial
- The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect
- Cannabis Co-Use Among Black Individuals with Chronic Pain Who Use Opioids: Associations with Other Substance Use and Pain Related Outcomes
- Cannabis Co-Use Among Black Individuals with Chronic Pain Who Use Opioids: Associations with Other Substance Use and Pain Related Outcomes
- Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo
- Opioid-free anesthesia : Wrong track or meaningful exit from the era of opioid-based analgesia?
- Delta opioid peptide [D-ala2, D-leu5]-Enkephalin's ability to enhance mitophagy via TRPV4 to relieve ischemia/reperfusion injury in brain microvascular endothelial cells
- Impact of intra-operative ketamine on postoperative outcomes in abdominal surgery: a narrative review
- Impact of intra-operative ketamine on postoperative outcomes in abdominal surgery: a narrative review
- Blockade of mGluR5 in nucleus accumbens modulates calcium sensor proteins, facilitates extinction, and attenuates reinstated morphine place preference in rats
- Blockade of mGluR5 in nucleus accumbens modulates calcium sensor proteins, facilitates extinction, and attenuates reinstated morphine place preference in rats
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Structural pharmacology and therapeutic potential of 5-methoxytryptamines
- Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia
- Evaluation of a Pilot Program to Prevent the Misuse of Prescribed Opioids Among Health Care Workers: Repeated Measures Survey Study
- Social support and the association between post-traumatic stress disorder and risk for long-term prescription opioid use
- Dabrafenib Alleviates Hepatotoxicity Caused by Lenvatinib via Inhibiting the Death Receptor Signaling Pathway
- Activation of M4 muscarinic receptors in the striatum reduces tic-like behaviours in two distinct murine models of Tourette syndrome
- Prevalence of Opioid Use Disorder and Opioid Overdose Rates Among People With Mental Illness
- Methadone Withdrawal-Induced Psychosis: A Case Report
- Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial
Evidence Blueprint
Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- A dual nociceptin and mu opioid receptor agonist exhibited robust antinociceptive effect with decreased side effects
- Peptide-derived ligands for the discovery of safer opioid analgesics
- Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype
- NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties
- The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception
- A Balancing Act: Learning from the Past to Build a Future-Focused Opioid Strategy
- Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use
- Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation
- Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics
- The effect of morphine administration on GluN3B NMDA receptor subunit mRNA expression in rat brain
- Selective targeting of mu opioid receptors to primary cilia
- Selective targeting of mu opioid receptors to primary cilia
- µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice
- Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users
- Opposing effects on descending control of nociception by mu and kappa opioid receptors in the anterior cingulate cortex
- Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone
- Tiam1-mediated maladaptive plasticity underlying morphine tolerance and hyperalgesia
- Tiam1-mediated maladaptive plasticity underlying morphine tolerance and hyperalgesia
- Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest
- Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal
- Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans
- The delta opioid receptor agonist KNT-127 relieves innate anxiety-like behavior in mice by suppressing transmission from the prelimbic cortex to basolateral amygdala
- The delta opioid receptor agonist KNT-127 relieves innate anxiety-like behavior in mice by suppressing transmission from the prelimbic cortex to basolateral amygdala
- Opioids in geriatric units in 14 Belgian hospitals: prevalence, dosage and associated factors
- Mu opioid receptor-positive neurons in the dorsal raphe nucleus are impaired by morphine abstinence
- Peripheral mu-opioid receptor activation by dermorphin [D-Arg2, Lys4] (1-4) amide alleviates behavioral and neurobiological aberrations in rat model of chemotherapy-induced neuropathic pain
- The common neurological basis and targeted therapeutic approaches for chronic pain and opioid addiction
- Opioid-induced hyperalgesia and tolerance are driven by HCN ion channels
- Neural network connectivity following opioid dependence is altered by a common genetic variant in the mu-opioid receptor, OPRM1 A118G
- All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects
- Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
- Cold nociception as a measure of hyperalgesia during spontaneous heroin withdrawal in mice
- Restless legs syndrome, neuroleptic-induced akathisia, and opioid-withdrawal restlessness: Shared neuronal mechanisms?
- Paternal morphine exposure in rats reduces social play in adolescent male progeny without affecting drug-taking behavior in juvenile males or female offspring
- A synergistic analgesic effect of morphine in combination with the CB1 receptor agonist, ACPA, in normal, hypothyroid, and hyperthyroid male rats
- Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice
- Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice
- Exploring the Function of (+)-Naltrexone Precursors: Their Activity as TLR4 Antagonists and Potential in Treating Morphine Addiction
- Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice
- Molecular mechanisms of morphine tolerance and dependence; novel insights and future perspectives
- A cre driver line for genetic targeting of kappa opioid receptor expressing cells
- Mimicking opioid analgesia in cortical pain circuits
- Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients
- Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
- Kappa opioid receptor in nucleus accumbens regulates depressive-like behaviors following prolonged morphine withdrawal in mice
- EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors
- Chronic intermittent ethanol exposure-induced m6A modifications around mRNA stop codons of opioid receptor genes
- Modulation of Nicotine-Associated Behaviour in Rats By μ-Opioid Signals from the Medial Prefrontal Cortex to the Nucleus Accumbens Shell
- IPAC integrates rewarding and environmental memory during the acquisition of morphine CPP
- Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality
- Opioid consumption before discharge predicts outpatient opioid use in adolescents undergoing surgery
- A novel inhibitory corticostriatal circuit that expresses mu opioid receptor-mediated synaptic plasticity
- Calcitonin receptor signaling in nucleus accumbens D1R- and D2R-expressing medium spiny neurons bidirectionally alters opioid taking in male rats
- Framing Cancer Survivors' Access to and Use and Disposal of Prescribed Opioids Within the Opioid Epidemic
- The impact of heroin self-administration and environmental enrichment on ventral tegmental CRF1 receptor expression
- Opioid-free anesthesia in oncologic surgery: the rules of the game
- Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review
- Establishing a research agenda for the study and assessment of opioid withdrawal
- Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation
- Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pKa Fluorinated Fentanyl Analogs, FF3 and NFEPP
- Contingent administration of typical and biased kappa opioid agonists reduces cocaine and oxycodone choice in a drug vs. food choice procedure in male rhesus monkeys
- The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
- Predictors of treatment retention and survival among methadone-maintained patients: A possible role for a functional delta opioid receptor gene variant
- Neuroprotective effects of naltrexone in a mouse model of post-traumatic seizures